Roles of Bone Modifying Agents in Prostate Cancer and Breast Cancer

Exploring the efficacy of bisphosphonates and denosumab in prostate cancer and the importance of adjuvant bisphosphonates in high-risk postmenopausal women with breast cancer, highlighting the significance of bone modifying agents in managing metastatic diseases.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app